SynCardia Granted FDA Conditional Approval To Conduct IDE Clinical Study For Freedomâ„¢ Driver System

SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWestâ„¢ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedomâ„¢ driver system, the first-ever U.S...